These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 13475433)

  • 1. Introduction to symposium on the management of hematologic disorders.
    WINTROBE MM; MOORE CV
    J Chronic Dis; 1957 Oct; 6(4):285-6. PubMed ID: 13475433
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of malignant blood diseases with compound E39.
    SAMPEY JR
    J S C Med Assoc (Columbia); 1959 Dec; 55():460-2. PubMed ID: 14441248
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction to a review series on rare systemic hematologic disorders.
    Berliner N; Sehn L
    Blood; 2020 Apr; 135(16):1305. PubMed ID: 32106304
    [No Abstract]   [Full Text] [Related]  

  • 4. IVIG: Current role in bone marrow transplant, malignancy, and immune hematologic disorders. Symposium proceedings. Scottsdale, Arizona, October 10-13, 1990.
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):1-133. PubMed ID: 1354892
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial. Symposium on Erythropoiesis and Red Cell Disorders.
    Weatherall D
    Br J Haematol; 2008 May; 141(3):275. PubMed ID: 18410565
    [No Abstract]   [Full Text] [Related]  

  • 6. Patients with cancer on the ICU: time for optimism.
    de Jonge E
    Neth J Med; 2014 Feb; 72(2):60-1. PubMed ID: 24659587
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of bone marow examination in patient management.
    Kitonyi GW
    East Afr Med J; 2010 Jan; 87(1):1-3. PubMed ID: 23057295
    [No Abstract]   [Full Text] [Related]  

  • 8. Hematologic aspects of mastocytosis: II: Management of hematologic disorders in association with systemic mast cell disease.
    Parker RI
    J Invest Dermatol; 1991 Mar; 96(3 Suppl):52S-53S; discussion 53S-54S, 60S-65S. PubMed ID: 16799610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New directions in hematologic biotherapy. Proceedings of a symposium. December 2, 1988, San Antonio, Texas, in conjunction with the 30th annual meeting of the American Society of Hematology.
    Semin Hematol; 1989 Jul; 26(3 Suppl 3):1-45. PubMed ID: 2799408
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of steroid hormones in the management of hematologic disorders.
    MOLONEY WC; DAVIS S; HIEBER RD
    GP; 1961 Jul; 24():101-6. PubMed ID: 13771913
    [No Abstract]   [Full Text] [Related]  

  • 11. Hematologic aspects of mastocytosis: II: management of hematologic disorders in association with systemic mast cell disease.
    Parker RI
    J Invest Dermatol; 1991 Mar; 96(3):52S-53S; discussion 53S-54S. PubMed ID: 2002265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and managed care issues in blood and marrow transplantation for hematologic diseases. Report of a symposium, 14 March 1996, Washington, DC.
    Beatty PG
    Exp Hematol; 1997 Oct; 25(11):1195-208. PubMed ID: 9328457
    [No Abstract]   [Full Text] [Related]  

  • 13. Symposium on pediatric hematology; foreword.
    Baehner RL
    Pediatr Clin North Am; 1980 May; 27(2):215-6. PubMed ID: 7383712
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings of a symposium on erythropoiesis and red cell disorders held at the Annual Scientific Meeting of the British Society for Haematology. April 2007. Bournemouth, United Kingdom.
    Br J Haematol; 2008 May; 141(3):275-410. PubMed ID: 18584805
    [No Abstract]   [Full Text] [Related]  

  • 15. Hematological Practice in India.
    Das R; Ahluwalia J; Sachdeva MU
    Hematol Oncol Clin North Am; 2016 Apr; 30(2):433-44. PubMed ID: 27040963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Beijing Blood Cell Growth Factors Symposium--blood cell growth factors: their present and future use in hematology and oncology.
    Nicola NA; Murphy MJ
    Cancer Res; 1992 Apr; 52(7):2012-3. PubMed ID: 1551131
    [No Abstract]   [Full Text] [Related]  

  • 17. National Antithrombin Investigators Program. Antithrombin Deficiency--Basis for Therapy. Proceedings of a symposium. Phoenix, Arizona, October 21-23, 1995.
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):1-74. PubMed ID: 8966624
    [No Abstract]   [Full Text] [Related]  

  • 18. Perioperative Approach to Anticoagulants and Hematologic Disorders.
    Kim J; Huh R; Jaffer AK
    Anesthesiol Clin; 2016 Mar; 34(1):101-25. PubMed ID: 26927742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symposium on hematology and hematologic malignancies.
    Med Clin North Am; 1984 May; 68(3):531-792. PubMed ID: 6748813
    [No Abstract]   [Full Text] [Related]  

  • 20. Introduction: from the genetic basis of blood disorders to gene transfer for the purpose of gene therapy.
    Luzzatto L
    Semin Hematol; 1998 Apr; 35(2):89-92. PubMed ID: 9565151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.